Showing results (221-230 of 353) with videos related to
Sort By:
Pageof 36
Arthritis and Rheumatism|October 29, 2011
Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin trapsNishant Dwivedi, Jagriti Upadhyay, Indira Neeli, et al.ACR Open Rheumatology|July 1, 2024
Multi-Autoantibody Testing Identifies Expansion of Reactivity to Targeted Antigens Before a Diagnosis of Rheumatoid ArthritisSalina H Goff, Dylan T Bergstedt, Marie L Feser, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 18, 2018
Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis Is Associated With Changes in Blood PressureJoshua F Baker, Brian Sauer, Chia-Chen Teng, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 25, 2009
Dual-energy X-ray absorptiometry and evaluation of the osteoporosis self-assessment tool in men with rheumatoid arthritisJ Steuart Richards, Justin Peng, Richard L Amdur, et al.The Journal of Rheumatology|August 17, 2014
Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritisGrant W Cannon, Scott L DuVall, Candace L Haroldsen, et al.Advances in Therapy|June 29, 2016
Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid ArthritisGrant W Cannon, Scott L DuVall, Candace L Haroldsen, et al.Respiratory Medicine|August 10, 2022
Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. VeteransJake G Natalini, Bryant R England, Joshua F Baker, et al.Arthritis Care & Research|November 10, 2025
Mortality in US Veterans with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors (ICIs)Madeline L O'Sullivan, Grant W Cannon, Brian C Sauer, et al.RMD Open|January 30, 2026
Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trialJosef S Smolen, Ted R Mikuls, James Galloway, et al.The American Journal of Medicine|December 4, 2018
Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized TrialTed R Mikuls, T Craig Cheetham, Gerald D Levy, et al.Pageof 36